CASE REPORT article

Front. Oncol.

Sec. Hematologic Malignancies

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1561923

This article is part of the Research TopicAntibody-based Novel Target Immunotherapy in Hematological MalignancyView all articles

Diffuse large B-cell lymphoma combined with two solid tumors: A case report

Provisionally accepted
Huiqing  QiuHuiqing Qiu*Yuqiao  ZhouYuqiao Zhou*Xiufang  ZhangXiufang ZhangShaojun  ZhouShaojun Zhou
  • The Second People's Hospital of Quzhou, Quzhou, China

The final, formatted version of the article will be published soon.

We report a rare case of multiple primary tumors in a 67-year-old male. The patient was treated surgically for a lumbar disc herniation with intraoperative findings of L5 nerve root tumor, and postoperative pathology confirmed a diagnosis of diffuse large B-cell lymphoma (DLBCL). Three months later, the patient was further pathologically diagnosed with prostate cancer. The multidisciplinary treatment team devised a staged therapeutic strategy: firstly, 2 cycles of R-CHOP chemotherapy for DLBCL, followed by local radiotherapy for the residual lesion of lumbar spine tumor, and then 2 cycles of R-MTX-CHOP chemotherapy in sequence; after the DLBCL was controlled, the patient underwent radical prostatectomy, which was followed by adjuvant endocrine therapy and pelvic lymph node radiotherapy. Post-treatment evaluation showed complete remission (CR) in both tumors.After five years of disease-free survival, the patient presented with enlarged cervical lymph nodes in October 2022. A biopsy confirmed DLBCL recurrence. The treatment team administered six cycles of R-GemOx chemotherapy, followed by maintenance therapy with the targeted agent Orelabrutinib.Subsequent assessments confirmed a second CR. In September 2024, a colonoscopy revealed a rectal tumor, which was pathologically diagnosed as rectal cancer. The patient underwent radical surgery, and the pathological staging was determined to be stage I. According to the literature search, this is the first reported case of triple primary malignancies involving DLBCL, prostate cancer and rectal cancer, which provides valuable experience in the clinical diagnosis and treatment of such rare cases.

Keywords: Multiple primary malignant tumors, DLBCL, prostate cancer, rectal cancer, solid tumors

Received: 16 Jan 2025; Accepted: 27 May 2025.

Copyright: © 2025 Qiu, Zhou, Zhang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Huiqing Qiu, The Second People's Hospital of Quzhou, Quzhou, China
Yuqiao Zhou, The Second People's Hospital of Quzhou, Quzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.